1. Home
  2. IQV

as of 11-28-2025 12:37pm EST

$230.79
$1.01
-0.44%
Stocks Health Care Biotechnology: Commercial Physical & Biological Resarch Nasdaq

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Chart Type:
Time Range:
Founded: 1982 Country:
United States
United States
Employees: N/A City: DURHAM
Market Cap: 36.4B IPO Year: 2013
Target Price: $236.71 AVG Volume (30 days): 1.4M
Analyst Decision: Buy Number of Analysts: 17
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 7.30 EPS Growth: -4.16
52 Week Low/High: $134.65 - $234.29 Next Earning Date: 10-28-2025
Revenue: $15,904,000,000 Revenue Growth: 3.85%
Revenue Growth (this year): 6.14% Revenue Growth (next year): 5.28%

AI-Powered IQV Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 76.67%
76.67%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest IQVIA Holdings Inc. News

IQV Breaking Stock News: Dive into IQV Ticker-Specific Updates for Smart Investing

All IQV News

Share on Social Networks: